Clinical Trial Update: Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ranolazine in individuals with chronic stable angina completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ranolazine (Ranexa) (Ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Angina Pectoris, Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-11-04